Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Morotti

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|May 26, 2016
LYMPHA Technique to Prevent Secondary Lower Limb LymphedemaFrancesco Boccardo, Mario Valenzano, Sergio Costantini, et al.
Journal of Clinical Medicine|November 27, 2024
Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian CancerGiulia Spagnol, Sofia Bigardi, Michela Zorzi, et al.
British Journal of Cancer|October 8, 2020
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancerMatteo Morotti, Christos E Zois, Rokaya El-Ansari, et al.
Oncogene|June 6, 2022
Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironmentTakeshi Motohara, Kenta Masuda, Matteo Morotti, et al.
Oncogene|December 21, 2018
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironmentTakeshi Motohara, Kenta Masuda, Matteo Morotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, Eleonora Ghisoni, Anita Wolfer, et al.
Cell Reports|November 2, 2023
Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoidsAbdulkhaliq Alsaadi, Mara Artibani, Zhiyuan Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.
Molecular Cancer Research : MCR|March 20, 2019
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine MetabolismAlessandro Valli, Matteo Morotti, Christos E Zois, et al.
Nature Immunology|September 15, 2020
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|May 26, 2016
LYMPHA Technique to Prevent Secondary Lower Limb LymphedemaFrancesco Boccardo, Mario Valenzano, Sergio Costantini, et al.
Journal of Clinical Medicine|November 27, 2024
Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian CancerGiulia Spagnol, Sofia Bigardi, Michela Zorzi, et al.
British Journal of Cancer|October 8, 2020
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancerMatteo Morotti, Christos E Zois, Rokaya El-Ansari, et al.
Oncogene|June 6, 2022
Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironmentTakeshi Motohara, Kenta Masuda, Matteo Morotti, et al.
Oncogene|December 21, 2018
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironmentTakeshi Motohara, Kenta Masuda, Matteo Morotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II StudySusana Banerjee, Eleonora Ghisoni, Anita Wolfer, et al.
Cell Reports|November 2, 2023
Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoidsAbdulkhaliq Alsaadi, Mara Artibani, Zhiyuan Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.
Molecular Cancer Research : MCR|March 20, 2019
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine MetabolismAlessandro Valli, Matteo Morotti, Christos E Zois, et al.
Nature Immunology|September 15, 2020
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
Pageof 6